17β-Estradiol up-regulates miR-155 expression and reduces TP53INP1 expression in MCF-7 breast cancer cells

Molecular and Cellular Biochemistry

Volumn 379, Issue 1-2, 2013, Pages 201-211

  Zhang, Chunmei ^a   Zhao, Jing ^a   Deng, Huayu ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

17 Estradiol; MCF 7 breast cells; miR 155; TP53INP1

Indexed keywords

ESTRADIOL; MICRORNA 155; NUCLEAR PROTEIN; TUMOR PROTEIN;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; CELL STRAIN MCF 7; COMPARATIVE STUDY; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

APOPTOSIS; BREAST NEOPLASMS; CARRIER PROTEINS; CASPASES; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAT-SHOCK PROTEINS; HUMANS; MCF-7 CELLS; MICRORNAS; RNA INTERFERENCE; RNA, MESSENGER; UP-REGULATION;

EID: 84878467113     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1642-6     Document Type: Article

References (47)

1. Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, Tujague M, Strom A, Treuter E, Warner M, Gustafsson JA (2007) Estrogen receptors: how do they signal and what are their targets. Physiol Rev 87:905-931. doi: 10.1152/physrev.00026.2006
2. Hall JM, Couse JF, Korach KS (2001) The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 276:36869-36872. doi: 10.1074/jbc.R100029200
3. Klinge CM (2009) Estrogen regulation of microRNA expression. Curr Genomics 10:169-183. doi: 10.2174/138920209788185289
4. Ali S, Coombes RC (2002) Endocrine-responsive breast cancer and strategies for combating resistance. Nat Rev Cancer 2:101-112. doi: 10.1038/nrc721
5. Klinge CM (2001) Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 29:2905-2919
6. Kushner PJ, Agard DA, Greene GL, Scanlan TS, Shiau AK, Uht RM, Webb P (2000) Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol 74:311-317
7. Safe S (2001) Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor-Sp1 interactions. Vitam Horm 62:231-252
8. Yu X, Zhang X, Dhakal IB, Beggs M, Kadlubar S, Luo D (2012) Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells. BMC Cancer 12:29. doi: 10.1186/1471-2407-12-29
9. Bhat-Nakshatri P, Wang G, Collins NR, Thomson MJ, Geistlinger TR, Carroll JS, Brown M, Hammond S, Srour EF, Liu Y, Nakshatri H (2009) Estradiol-regulated microRNAs control estradiol response in breast cancer cells. Nucleic Acids Res 37:4850-4861. doi: 10.1093/nar/gkp500
10. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215-233. doi: 10.1016/j.cell.2009.01.002
11. Wickramasinghe NS, Manavalan TT, Dougherty SM, Riggs KA, Li Y, Klinge CM (2009) Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells. Nucleic Acids Res 37:2584-2595. doi: 10.1093/nar/gkp117
12. Katchy A, Edvardsson K, Aydogdu E, Williams C (2012) Estradiol-activated estrogen receptor alpha does not regulate mature microRNAs in T47D breast cancer cells. J Steroid Biochem Mol Biol 128:145-153. doi: 10.1016/j.jsbmb.2011.10.008
13. Zhao Y, Srivastava D (2007) A developmental view of microRNA function. Trends Biochem Sci 32:189-197. doi: 10.1016/j.tibs.2007.02.006
14. Ventura A, Jacks T (2009) MicroRNAs and cancer: short RNAs go a long way. Cell 136:586-591. doi: 10.1016/j.cell.2009.02.005
15. Yamagata K, Fujiyama S, Ito S, Ueda T, Murata T, Naitou M, Takeyama K, Minami Y, O'Malley BW, Kato S (2009) Maturation of microRNA is hormonally regulated by a nuclear receptor. Mol Cell 36:340-347. doi: 10.1016/j.molcel. 2009.08.017
16. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Menard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65:7065-7070. doi: 10.1158/0008-5472.CAN-05-1783
17. Zhu W, Qin W, Atasoy U, Sauter ER (2009) Circulating microRNAs in breast cancer and healthy subjects. BMC Res Notes 2:89. doi: 10.1186/1756-0500-2-89
18. Lu J, Tsourkas A (2009) Imaging individual microRNAs in single mammalian cells in situ. Nucleic Acids Res 37:e100. doi: 10.1093/nar/gkp482
19. Kong W, He L, Coppola M, Guo J, Esposito NN, Coppola D, Cheng JQ (2010) MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. J Biol Chem 285:17869-17879. doi: 10.1074/jbc.M110. 101055
20. Jiang S, Zhang HW, Lu MH, He XH, Li Y, Gu H, Liu MF, Wang ED (2010) MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res 70:3119-3127. doi: 10.1158/0008-5472.CAN-09-4250
21. Kong W, Yang H, He L, Zhao JJ, Coppola D, Dalton WS, Cheng JQ (2008) MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol 28:6773-6784. doi: 10.1128/MCB.00941-08
22. Han D, Denison MS, Tachibana H, Yamada K (2002) Effects of estrogenic compounds on immunoglobulin production by mouse splenocytes. Biol Pharm Bull 25:1263-1267
23. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9:189-198. doi: 10.1016/j.ccr.2006.01.025
24. Raponi M, Dossey L, Jatkoe T, Wu X, Chen G, Fan H, Beer DG (2009) MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res 69:5776-5783. doi: 10.1158/0008-5472.CAN-09-0587
25. Nikiforova MN, Tseng GC, Steward D, Diorio D, Nikiforov YE (2008) MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J Clin Endocrinol Metab 93:1600-1608. doi: 10.1210/jc.2007-2696
26. Ryu JK, Hong SM, Karikari CA, Hruban RH, Goggins MG, Maitra A (2010) Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma. Pancreatology 10:66-73. doi: 10.1159/000231984
27. Habbe N, Koorstra JB, Mendell JT, Offerhaus GJ, Ryu JK, Feldmann G, Mullendore ME, Goggins MG, Hong SM, Maitra A (2009) MicroRNA miR-155 is a biomarker of early pancreatic neoplasia. Cancer Biol Ther 8:340-346
28. Gironella M, Seux M, Xie MJ, Cano C, Tomasini R, Gommeaux J, Garcia S, Nowak J, Yeung ML, Jeang KT, Chaix A, Fazli L, Motoo Y, Wang Q, Rocchi P, Russo A, Gleave M, Dagorn JC, Iovanna JL, Carrier A, Pebusque MJ, Dusetti NJ (2007) Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc Natl Acad Sci USA 104:16170-16175. doi: 10.1073/pnas.0703942104
29. Greither T, Grochola LF, Udelnow A, Lautenschlager C, Wurl P, Taubert H (2010) Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int J Cancer 126:73-80. doi: 10.1002/ijc.24687
30. Pedersen IM, Otero D, Kao E, Miletic AV, Hother C, Ralfkiaer E, Rickert RC, Gronbaek K, David M (2009) Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas. EMBO Mol Med 1:288-295. doi: 10.1002/emmm.200900028
31. Costinean S, Sandhu SK, Pedersen IM, Tili E, Trotta R, Perrotti D, Ciarlariello D, Neviani P, Harb J, Kauffman LR, Shidham A, Croce CM (2009) Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice. Blood 114:1374-1382. doi: 10.1182/blood-2009-05-220814
32. Ferraro L, Ravo M, Nassa G, Tarallo R, De Filippo MR, Giurato G, Cirillo F, Stellato C, Silvestro S, Cantarella C, Rizzo F, Cimino D, Friard O, Biglia N, De Bortoli M, Cicatiello L, Nola E, Weisz A (2012) Effects of oestrogen on microRNA expression in hormone-responsive breast cancer cells. Horm Cancer 3:65-78. doi: 10.1007/s12672-012-0102-1
33. Ito Y, Motoo Y, Yoshida H, Iovanna JL, Takamura Y, Miya A, Kuma K, Miyauchi A (2006) Decreased expression of tumor protein p53-induced nuclear protein 1 (TP53INP1) in breast carcinoma. Anticancer Res 26:4391-4395
34. Cano CE, Gommeaux J, Pietri S, Culcasi M, Garcia S, Seux M, Barelier S, Vasseur S, Spoto RP, Pebusque MJ, Dusetti NJ, Iovanna JL, Carrier A (2009) Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant function. Cancer Res 69:219-226. doi: 10.1158/0008-5472.CAN-08-2320
35. Tomasini R, Samir AA, Vaccaro MI, Pebusque MJ, Dagorn JC, Iovanna JL, Dusetti NJ (2001) Molecular and functional characterization of the stress-induced protein (SIP) gene and its two transcripts generated by alternative splicing. SIP induced by stress and promotes cell death. J Biol Chem 276:44185-44192. doi: 10.1074/jbc.M105647200
36. Tomasini R, Samir AA, Pebusque MJ, Calvo EL, Totaro S, Dagorn JC, Dusetti NJ, Iovanna JL (2002) P53-dependent expression of the stress-induced protein (SIP). Eur J Cell Biol 81:294-301
37. Okamura S, Arakawa H, Tanaka T, Nakanishi H, Ng CC, Taya Y, Monden M, Nakamura Y (2001) p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis. Mol Cell 8:85-94
38. Jiang PH, Motoo Y, Garcia S, Iovanna JL, Pebusque MJ, Sawabu N (2006) Down-expression of tumor protein p53-induced nuclear protein 1 in human gastric cancer. World J Gastroenterol 12:691-696
39. Tomasini R, Seux M, Nowak J, Bontemps C, Carrier A, Dagorn JC, Pebusque MJ, Iovanna JL, Dusetti NJ (2005) TP53INP1 is a novel p73 target gene that induces cell cycle arrest and cell death by modulating p73 transcriptional activity. Oncogene 24:8093-8104. doi: 10.1038/sj.onc.1208951
40. Yanamadala V, Negoro H, Denker BM (2009) Heterotrimeric G proteins and apoptosis: intersecting signaling pathways leading to context dependent phenotypes. Curr Mol Med 9:527-545
41. Walsh JG, Cullen SP, Sheridan C, Luthi AU, Gerner C, Martin SJ (2008) Executioner caspase-3 and caspase-7 are functionally distinct proteases. Proc Natl Acad Sci USA 105:12815-12819. doi: 10.1073/pnas.0707715105
42. Gutzman JH, Nikolai SE, Rugowski DE, Watters JJ, Schuler LA (2005) Prolactin and estrogen enhance the activity of activating protein 1 in breast cancer cells: role of extracellularly regulated kinase 1/2-mediated signals to c-fos. Mol Endocrinol 19:1765-1778. doi: 10.1210/me.2004-0339
43. van den Berg A, Kroesen BJ, Kooistra K, de Jong D, Briggs J, Blokzijl T, Jacobs S, Kluiver J, Diepstra A, Maggio E, Poppema S (2003) High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma. Genes Chromosomes Cancer 37:20-28. doi: 10.1002/gcc.10186
44. Xiao B, Liu Z, Li BS, Tang B, Li W, Guo G, Shi Y, Wang F, Wu Y, Tong WD, Guo H, Mao XH, Zou QM (2009) Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the inflammatory response. J Infect Dis 200:916-925. doi: 10.1086/605443
45. Yin Q, Wang X, McBride J, Fewell C, Flemington E (2008) B-cell receptor activation induces BIC/miR-155 expression through a conserved AP-1 element. J Biol Chem 283:2654-2662. doi: 10.1074/jbc.M708218200
46. Yin Q, McBride J, Fewell C, Lacey M, Wang X, Lin Z, Cameron J, Flemington EK (2008) MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways. J Virol 82:5295-5306. doi: 10.1128/JVI.02380-07
47. Dai Y, Diao Z, Sun H, Li R, Qiu Z, Hu Y (2011) MicroRNA-155 is involved in the remodelling of human-trophoblast-derived HTR-8/SVneo cells induced by lipopolaccharides. Hum Reprod 26:1882-1891. doi: 10.1093/humrep/der118